# CPG Sec. 252.100 Source Plasma - Regulatory Action Based on Overbleeding (Obsolete, Withdrawn on 11/28/2017) - FDA Guidance Document

Source: https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-252100-source-plasma-regulatory-action-based-on-overbleeding-obsolete-withdrawn-on-11282017/0da0f52d-6544-41e5-9a6a-cc3e8746fdec

> FDA guidance document: CPG Sec. 252.100 Source Plasma - Regulatory Action Based on Overbleeding (Obsolete, Withdrawn on 11/28/2017). Issue date: February 28, 1995. Get complete insights and analysis.

---

## Details

- Title: CPG Sec. 252.100 Source Plasma - Regulatory Action Based on Overbleeding (Obsolete, Withdrawn on 11/28/2017)
- Communication Type: Compliance Policy Guide (CPG)
- Product Type: Biologics
- Office Name: Office of Regulatory Affairs
- Issue Date: 1995-02-28

## Related Documents

- [CPG Sec. 256.100 Plasmapheresis - 48-hour Period Between Plasmapheresis Procedures (Obsolete, Withdrawn on 11/28/2017)](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-256100-plasmapheresis-48-hour-period-between-plasmapheresis-procedures-obsolete-withdrawn-on-11282017/ae4eed14-2c34-4be8-b659-692a34b025b9)
- [CPG Sec. 252.110 Volume Limits for Automated Collection of Source Plasma (Obsolete, Withdrawn on 11/28/2017)](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-252110-volume-limits-for-automated-collection-of-source-plasma-obsolete-withdrawn-on-11282017/876c7326-82c4-4376-bd6e-288ef1bd6166)
- [CPG Sec. 250.100 Source Plasma – Guidelines for Informed Consent Forms (Obsolete, Withdrawn on 11/28/2017)](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-250100-source-plasma-guidelines-for-informed-consent-forms-obsolete-withdrawn-on-11282017/64ae053c-da0b-451e-a25a-c46238cb6e5a)